Curis, Inc. Reports Third Quarter 2009 Financial Results

October 29, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today reported its financial results for the third quarter ended September 30, 2009.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Curis, Inc.